Position in ONC
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$44,940,053
+$16,229,885 QoQ
Shares Held
157,701
+63.1% QoQ
Ownership
0.139%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#28
of 282 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ONC Over Time
Shares Held
Position Value (USD)
Derivatives in ONC
reported options exposure · as of Sep 30, 2020CallValue
$24,347,400
CallShares
85,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026GOLDMAN SACHS GROUP INC holds $13,040,376,854 across 359 Biotechnology names. ONC ranks #72 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,481,761 | $1,232,765,138 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,163,191 | $725,296,113 | |
| 3 | ROIV |
Roivant Sciences Ltd.
|
18,556,458 | $656,713,046 | |
| 4 | TECH |
BIO-TECHNE Corp
|
7,343,324 | $518,805,838 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
2,133,101 | $399,487,154 | |
| 6 | MRNA |
Moderna, Inc.
|
4,671,950 | $327,176,656 | |
| 7 | TNGX |
Tango Therapeutics, Inc.
|
9,980,620 | $311,994,180 | |
| 8 | INCY |
Incyte Corp
|
2,305,782 | $261,383,446 |
All Filings in ONC
Export CSV
27 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $44,940,053 | 157,701 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $28,710,168 | 96,677 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $45,180,799 | 148,714 | Shares | Defined | 2026-03-25 | |
| 2025-09-30 | $15,069,500 | 44,231 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $17,006,626 | 70,255 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $26,710,219 | 98,138 | Shares | Defined | 2025-06-27 | |
| 2024-12-31 | $8,755,992 | 47,404 | Shares | Defined | 2025-02-11 | |
| 2024-09-30 | $6,883,027 | 30,658 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $11,574,246 | 81,126 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $9,130,829 | 58,385 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $38,658,180 | 214,339 | Shares | Defined | 2024-05-14 | |
| 2023-09-30 | $14,008,454 | 77,881 | Shares | Defined | 2024-05-15 | |
| 2023-06-30 | $12,649,671 | 70,946 | Shares | Defined | 2024-05-14 | |
| 2023-03-31 | $14,271,318 | 66,215 | Shares | Defined | 2024-05-14 | |
| 2022-12-31 | $15,030,919 | 68,341 | Shares | Defined | 2024-05-14 | |
| 2022-09-30 | $38,382,443 | 284,694 | Shares | Defined | 2024-05-14 | |
| 2022-06-30 | $39,376,971 | 243,293 | Shares | Defined | 2024-05-14 | |
| 2022-03-31 | $45,014,293 | 238,676 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $51,054,048 | 188,440 | Shares | Defined | 2022-02-17 | |
| 2021-09-30 | $59,437,257 | 163,739 | Shares | Defined | 2022-01-20 | |
| 2021-06-30 | $107,387,582 | 312,910 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $141,493,474 | 406,497 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $77,930,165 | 301,599 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $24,347,400 | 85,000 | Call | Defined | 2020-11-13 | |
| 2020-09-30 | $15,420,783 | 53,836 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $10,284,379 | 54,588 | Shares | Defined | 2020-08-12 | |
| 2020-03-31 | $10,946,940 | 88,920 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||